TCR-Redirected T Cells Therapy in Patient With HBV Related HCC
Condition(s):Hepatocellular CarcinomaLast Updated:April 10, 2019Recruiting
Hide Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:April 10, 2019Recruiting
Condition(s):Cardiac RepolarizationLast Updated:August 7, 2013Completed
Condition(s):Ischemic StrokeLast Updated:September 22, 2020Completed
Condition(s):Head and Neck CancerLast Updated:August 29, 2016Completed
Condition(s):Hepatocellular CarcinomaLast Updated:June 1, 2023Withdrawn
Condition(s):Multiple MyelomaLast Updated:December 19, 2022Terminated
Condition(s):AnesthesiaLast Updated:March 25, 2020Completed
Condition(s):Bone Loss; Muscle Atrophy; Bariatric SurgeryLast Updated:June 10, 2022Recruiting
Condition(s):End Stage Renal Disease; Kidney Disease; Protein Energy WastingLast Updated:April 11, 2018Completed
Condition(s):Acute Myeloid Leukemia (AML); Multiple Myeloma (MM)Last Updated:June 22, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.